MFX
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$2.61M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MFX operates in Healthcare & Life Sciences and is based in Stevenage. Its latest recorded funding round was a Grant round in December 2023.
MFX is a biotechnology company that provides a scalable bioreactor and data platform for cell and gene therapy research, development, and manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MFX Comparables
Compare MFX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 88% | |
| Aglaris | 87% | |
| Adva Biotechnology | 87% |
For institutional investors. Book with your work email.
MFX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Dec 19, 2023 | ||||
| VC Round | Dec 8, 2022 | ||||
| Seed | Apr 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MFX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Cambridge Angels | Seed |
| UK Innovation & Science Seed Fund | VC Round, Seed |
| Perscitus LLP | VC Round |
| 88 Capital & Investments | Seed |
| Puffin Point | VC Round |
| Longwall Venture Partners | VC Round, Grant, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
Received grant funding.
- Mar 17, 2025
Dr. Katy Newton appointed to lead innovation in cell-based therapies.
For institutional investors. Book with your work email.
MFX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MFX's valuation, stock price, and market status.
Is MFX a public or private company?
MFX is a private company.
What is the current stock price of MFX?
MFX is a private company, so its shares have no public market price. Caplight tracks MFX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MFX worth (valuation)?
Valuation information for MFX is not publicly available.
Can I buy MFX stock?
MFX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MFX's last funding round?
MFX's most recent funding round was Grant on November 19, 2025.
Who are the main investors in MFX?
Key investors in MFX include UK Innovation & Science Seed Fund, Longwall Venture Partners.
Will MFX IPO soon?
No public IPO plans have been announced for MFX.
How can I track MFX secondary market activity?
Caplight tracks bids, offers, and trades in MFX's shares on secondary markets.